Details for Patent: 12,390,540
Which drugs does patent 12,390,540 protect, and when does it expire?
Patent 12,390,540 protects POSLUMA and is included in one NDA.
This patent has thirty patent family members in twenty countries.
Summary for Patent: 12,390,540
| Title: | Dual mode radiotracer and -therapeutics |
| Abstract: | The present invention relates to a ligand-SIF A-chelator conjugate, comprising, within in a single molecule three separate moieties: (a) one or more ligands which are capable of binding to a disease-relevant target molecule, (b) a silicon-fluoride acceptor (SIFA) moiety which comprises a covalent bond between a silicon atom and a fluorine atom, and (c) one or more chelating groups, optionally containing a chelated nonradioactive or radioactive cation. |
| Inventor(s): | Alexander Josef Wurzer, Hans-Jürgen Wester, Matthias Johannes Eiber |
| Assignee: | Technische Universitaet Muenchen Klinikum Rechts Der Isar , Technische Universitaet Muenchen |
| Application Number: | US17/849,297 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 12,390,540
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blue Earth | POSLUMA | flotufolastat f-18 gallium | SOLUTION;INTRAVENOUS | 216023-001 | May 25, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,390,540
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018308699 | ⤷ Start Trial | |||
| Australia | 2024200440 | ⤷ Start Trial | |||
| Brazil | 112020001785 | ⤷ Start Trial | |||
| Canada | 3071315 | ⤷ Start Trial | |||
| China | 111132700 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
